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β chains (the vast majority) or γ and δ chains. Each of these 
TCR chains is composed of several distinct regions called 
variable (V), joining (J), diversity (D), and constant (C). TCRs 
are unique to individual T lymphocytes and are formed by 
the rearrangement and assembly of the TCR genes during 
T lymphocyte development in the thymus, a process called 
somatic recombination. The gene segments that encode the 
separate distinct regions of the TCR protein exist as multiple 
nonidentical sets. There are, for example, 12 TCR-γ V-region 
gene segments.
During T-cell maturation, the TCR genes undergo rear-
rangement. Thus, in TCR-γ chain assembly, a single V 
WHAT TCR GENE REARRANGEMENT 
ANALYSIS DOES
•  TCR gene rearrangement studies, as demonstrated 
by PCR and gel electrophoresis, are used to detect 
malignant T-cell clones in CTCL.
•  It is an excellent tool to aid in the diagnosis of 
CTCL, although it cannot be used to make a 
diagnosis of CTCL on its own.
LIMITATIONS 
•  Lack of amplification of the TCR-γ gene may occur 
owing to loss of representative gene segments or 
cells, variations in section thickness and cell size, or 
degradation of DNA in the histological processing 
of tissue.
•  It can produce false-negative results due to factors 
such as poor tissue sampling, a biopsy specimen 
that has a small number of malignant T cells, or the 
possibility that the primers used may not cover all 
possible TCR-γ gene rearrangements.
•  The high sensitivity of PCR means it can also 
produce false-positive results by detecting a 
dominant clone in other benign chronic dermatoses.
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Primary cutaneous T-cell lymphomas (CTCLs) are a hetero-
geneous group of extranodal non-Hodgkin’s lymphoma that 
present on the skin with no evidence of extracutaneous dis-
ease at the time of diagnosis (Willemze et al., 2005). The 
general consensus is that CTCLs are typically monoclonal in 
origin, developing from a single T cell that forms a malignant 
clone of T cells in the skin (Kandolf Sekulovic et al., 2007). 
Mycosis fungoides (MF) and Sézary syndrome (SS) are the two 
most common types of CTCL, accounting for almost 65% of 
CTCLs. In the early stages of disease, MF can pose a diagnos-
tic quandary for physicians and often leads to a delay in diag-
nosis despite multiple skin biopsies. This occurs because the 
neoplastic T cells in the skin in the early stages of MF are far 
outnumbered by the body’s immune response through tumor-
reactive T cells and other effector cells in the skin. Together 
with the neoplastic T cells, these resemble a nonspecific 
inflammatory infiltrate on microscopy, making it difficult to 
distinguish from other benign dermatoses such as eczema or 
psoriasis (Mishra and Porcu, 2011). SS often has nonspecific 
features histologically or they are less marked changes than 
are typically seen in MF, thus also posing diagnostic difficul-
ties from skin biopsy alone (Willemze et al., 2005).
T-cell receptor (TCR) gene rearrangement studies dem-
onstrated by PCR are used to detect clonality and can be a 
highly reliable method to aid in diagnosing CTCL (Ponti et al., 
2008). The technique is dependent on the fact that T cells bear 
a unique antigen receptor on their cell surface that serves as 
a specific marker for that cell and its clonal progeny. If a cell 
undergoes neoplastic transformation, its TCR becomes a tumor 
marker specific to that cell lineage (Wood, 2001). Using PCR 
and high-resolution electrophoresis, a TCR clone can be dem-
onstrated in up to 90% of skin biopsies in MF cases (Bottaro et 
al., 1994).
This article describes how the TCR gene rearrangement 
analysis is carried out and interpreted, as well as its advan-
tages, limitations, and use in the diagnosis of CTCL.
HOW IS TCR GENE REARRANGEMENT ANALYSIS PERFORMED?
TCRs are protein heterodimers expressed on the cell sur-
face of T lymphocytes. They are composed of either α and 
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1. Extraction of genomic DNA from the skin specimen. 
Genomic DNA can be isolated from both fresh and forma-
lin-fixed paraffin-embedded tissue. Although both methods 
are acceptable, fresh-frozen samples are preferred because 
of the higher sensitivity associated with isolating genomic 
DNA from them. If the specimen is in formalin-fixed paraffin, 
then DNA is isolated from paraffin blocks by deparaffiniz-
ing specimens by incubation with xylene, 100% ethanol, and 
acetone. After this, a mixture including proteinase K is added 
to the specimen and incubated overnight at 37 °C or for 
3 hours at 55 °C (Sprouse et al., 2000).
2. PCR-based amplification of the TCR-γ gene 
rearrangements from the genomic DNA. Once the 
genomic DNA is extracted, the PCR-based amplification 
process is started. Amplification is performed by adding 
genomic DNA as the template, combined with primer, 
region from several V gene segments is positioned next to 
a single J region that has also been selected from several 
J gene segments to make a highly exclusive rearranged 
V/J gene region that is eventually expressed on the TCR-γ 
protein. To further add to the exclusivity of the TCR, there 
is then random loss of the original nucleotides at the ends 
where the V and J segments join. This loss is replaced 
by the insertion of N nucleotides at the joins. The result 
is a unique V/N nucleotide/J structure that serves as a 
“fingerprint” for that particular T cell and all its clonal 
progeny (Wood, 2001; Wood et al., 1994).
TCR gene rearrangement analysis with PCR can be 
performed on any TCR gene. The TCR-γ gene is preferred 
because it is rearranged early in T-cell development both 
in α/β and in γ/δ T cells, and T cells generally retain intact 
rearranged TCR-γ genes although the protein may no lon-
ger be expressed on mature T cells. The γ gene structure 
is also simpler, with only 12 variable segments compared 
with other TCR genes such as the TCR-β gene, which has 
over 60 variable segments. Thus, fewer sets of primers are 
needed to detect most of the possible gene rearrangements 
(Kandolf Sekulovic et al., 2007; Wood, 2001).
The process involves three main steps: (1) extraction 
of genomic DNA from the skin specimen; (2) PCR-based 
amplification of the TCR-γ gene rearrangements from the 
genomic DNA; and (3) detection of the PCR products, most 
commonly by fractionation of the resulting products by gel 
electrophoresis (Figure 1) (Wood et al., 1994).
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Figure 1. Method of TCR-γ gene rearrangement. (a) A skin biopsy specimen 
is taken from active lesions. (b) The skin specimen is placed into a container, 
which is placed on ice for transport. (c) The genomic DNA is isolated, and 
PCR amplification is started. (d) The PCR products are analyzed using gel 
electrophoresis. (c, Concept by E.K. Martin, Svenska Dagbladet. d, Adapted 
from http://cg.scs.carleton.ca/~morin/teaching/compbio/electro.html.)
Figure 2. PCR/denaturing gradient gel electrophoresis (DGGE): dominant 
T-cell clonal patterns. Discrete sharp bands are present in lanes 1–6, 8, 9, 
11, 12, and 15. These bands reflect the presence of dominant TCR-γ gene 
rearrangements and contrast with the diffuse smears present in Figure 3 
and also in lanes 7, 13, and 16–20, which correspond to the absence of 
detectable dominant TCR-γ gene rearrangements. Reprinted with permission 
from Wood et al. (1994).
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nucleotides including all four bases (adenine, thymine, 
cytosine, and guanine), and DNA polymerase to a test tube. 
Next, the test tube is placed in a thermocycler machine 
that raises the temperature to denature the DNA, then low-
ers the temperature to allow primers and DNA to anneal, 
and finally raises the temperature again to allow the DNA 
polymerase to extend the primers by adding nucleotides 
to the DNA template strand (Sprouse et al., 2000; Guitart 
and Kaul, 1999). (See the recent Research Techniques Made 
Simple article on PCR (Garibyan and Avashia, 2013) for a 
detailed description of the process.)
3. Detection of the PCR products. The final step involves 
analysis of the PCR products by gel electrophoresis to 
separate the PCR products according to their nucleotide 
sequence and size. The gel contains a urea/formamide-
gradient that results in partial melting of the PCR products 
and therefore reduces the mobility at a point in the gradi-
ent determined by the nucleotide sequence. If there are 
enough numbers and fragments that are of identical size 
and sequence, as is produced by PCR of TCR genes from 
the genomic DNA of a monoclonal T-cell population, an 
intense clonal band is visible under UV light after the gel is 
stained with ethidium bromide (Figure 2). If there are het-
erogeneous fragments amplified from polyclonal cells, then 
only a diffuse smear is seen (Figure 3) (Bottaro et al., 1994; 
see Figure 1).
ADVANTAGES
Prior to the use of PCR and gel electrophoresis to detect clon-
ality in suspected cases of CTCL, the Southern blot technique 
was commonly used. In comparison to the above technique, 
the Southern blot analysis is time consuming, requires large 
skin samples, and can detect only 5–10% of clonal subpopu-
lations of cells (Kandolf Sekulovic et al., 2007).
PCR has several additional advantages over Southern 
blot analysis. It is a much more sensitive technique that can 
be done with standard-size punch and shave biopsy speci-
mens; in addition, it is less expensive than Southern blot 
analysis, and it takes only 2–3 days to complete. Unlike 
Southern blotting, which typically requires radiolabeled 
hybridization probes, PCR does not require radioactive 
agents. In addition, PCR can analyze lesions with sparse 
lymphocytic infiltrates, as is often the case in early-stage 
MF. Despite the low numbers of tumor cells, amplification 
ensures they are detected (Bottaro et al., 1994).
LIMITATIONS
Although the advent of PCR and gel electrophore-
sis has increased the sensitivity of detecting TCR-γ gene 
rearrangement, several limitations to this technique can 
lead to false-negative results. The TCR-γ gene of selected T 
lympho cytes may not amplify owing to factors such as sec-
tion thickness and cell size variations or the degradation of 
DNA in the histological processing of tissue (Gellrich et al., 
2000). Other limitations include poor tissue sampling (i.e., 
a biopsy taken from a skin sample with a small number of 
malignant T cells) and the possibility that the primers used 
may not cover all possible TCR-γ gene rearrangements. 
Finally, in the later stages of the disease, TCR gene deletion 
is possible as the cell undergoes malignant transformation 
leading to nonamplification of TCR-γ gene sequences 
(Kandolf Sekulovic et al., 2007). False positives can also 
occur because of the presence of rare benign lymphoid infil-
trates, leading to “pseudoclonal” results. Another cause of 
false positives is cross-contamination of specimens by clonal 
DNA from positive controls. For these reasons, it is not pos-
sible to rely on the results of the TCR gene rearrangement 
analysis solely to diagnose a patient with CTCL.
WHEN IS TCR GENE REARRANGEMENT ANALYSIS USED  
IN DERMATOLOGY?
The most common use of TCR gene rearrangement analysis is 
to aid in the diagnosis of CTCL. In the case of SS, the leukemic 
Figure 3. PCR/denaturing gradient gel electrophoresis (DGGE): polyclonal 
T-cell pattern. Vy1-8 PCR products (lanes 1–6) and Vy9 PCR products 
(lanes 7–13) were subjected to DGGE, stained with ethidium bromide, and 
photographed using UV illumination. Lanes 1–5 and 7–12 contain diffuse 
smears lacking discrete bands. This is the typical result in the absence of 
detectable dominant TCR-γ gene rearrangements. Lane 6 shows Vy1-8 
carryover–negative control containing all reagents except target DNA. 
Reprinted with permission from Wood et al. (1994).
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form of CTCL, the presence of a T-cell clone in the skin 
and blood, together with certain cytomorphologic features 
and immunophenotypic features in the blood, is helpful in 
making a diagnosis and differentiating from benign inflam-
matory conditions that can mimic this condition. TCR 
gene rearrangement has not been shown to improve with 
resolution of disease and thus cannot be used as a marker 
of disease activity.
It is important to note that a positive clonality result does 
not necessarily equate to malignancy, as several benign 
dermatoses can produce a similar pattern, including lym-
phomatoid papulosis, pityriasis lichenoides et varioliformis 
acuta, lymphomatoid drug eruptions, actinic reticuloid, 
and lichen planus (Gellrich et al., 2000). It is essential that 
clinical, histological, and immunological data be taken into 
consideration when making a diagnosis of CTCL and that 
the TCR gene rearrangement analysis is used as an adjunct 
to help make the case for or against a diagnosis of CTCL, 
rather than as the sole diagnostic feature.
IS TCR GENE REARRANGEMENT ANALYSIS USED FOR 
ANYTHING ELSE?
TCR gene rearrangement is an important event in T-cell 
ontogeny, and any disruption in this cycle may result in 
disease. T cells have been implicated in the pathogenesis 
of immunodeficiency, autoimmunity, and atopy. One of 
the most pivotal uses of TCR gene rearrangement analy-
sis is in the diagnosis of lymphocytic disease and in dis-
tinguishing it from reactive lymphoid proliferations. It has 
been used in monitoring minimal residual disease after 
bone marrow transplantation, aiding in the diagnosis of 
immunodeficiency states, and characterizing T cells at dis-
ease sites in patients with allergy or autoimmune disease 
(Bottaro et al., 1994).
SUMMARY AND FUTURE DIRECTIONS
TCR gene rearrangement analysis with PCR and gel elec-
trophoresis is a widely used adjunct in the diagnosis 
of CTCL. Most studies on TCR gene rearrangement have 
focused on the diagnosis of CTCL or response to therapy. 
Few have addressed whether these molecular methods are 
a useful staging tool for predicting prognosis. The techni-
cal advantages of PCR make it the method of choice for 
detecting clonality, and it will continue to be the method 
of choice until newer methods are shown to have advan-
tages over this technique.
MF disseminates to blood, lymph nodes, and viscera 
in the advanced stages. A positive clone in the blood is 
detected more frequently with progressive stages of cuta-
neous disease, such as those with cutaneous tumors or 
erythroderma. Studies have shown that the detection of a 
clone in dermatopathic lymph nodes (i.e., early-stage MF) 
can be associated with a worse prognosis. T-cell clones 
have even been found in the blood of a significant propor-
tion of patients with early-stage MF, and the presence of a 
peripheral blood clone was shown to be associated with a 
worse outcome (Bottaro et al., 1994). To date, such stud-
ies have involved small numbers of patients, and studies 
with a larger patient population will be needed to confirm 
these observations and to evaluate how best to incorporate 
these data in the staging of MF.
1.  In what way does the TCR gene rearrangement 
study aid in CTCL?
A.    A TCR gene is lost in CTCL and thus serves as an 
indicator for diagnosis of CTCL.
B.    A TCR gene serves as a marker for the 
monoclonal T cell, thus aiding in diagnosis.
C.    A TCR gene rearrangement study, if positive,  
is diagnostic of CTCL.
D.    A TCR gene rearrangement test is not useful 
because it is nearly always negative in patients 
with CTCL.
2.  A major advantage of using PCR compared with 
Southern blotting is:
A.   Low sensitivity.
B.   Low specificity.
C.   High specificity.
D.   High sensitivity.
3.  A positive TCR gene rearrangement test is 
interpreted positive when there is a:
A.   Polyclonal band detection on DGGE.
B.   Smear detected on DGGE.
C.   Monoclonal band detected on DGGE.
D.   Blank space on DGGE.
4.  TCR gene rearrangement studies should be used:
A.   To help confirm a clinical suspicion of CTCL.
B.    As a screening tool for all pruritic patients with 
no histologically confirmed diagnosis.
C.    To help confirm a histological and clinical 
suspicion of CTCL.
D.   To rule out CTCL in a pruritic patient.
5.  All of the following are limitations of PCR in TCR 
gene rearrangement studies, except:
A.    Loss of gene as the cell undergoes malignant 
transformation.
B.   Poor tissue sampling.
C.   Inadequate number of primers.
D.   Inability to use paraffinized tissue for the test.
QUESTIONS
This article has been approved for 1 hour of Category 1 CME credit.  
To take the quiz, with or without CME credit, follow the link under  
the “CME ACCREDITATION” heading.
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MF is often preceded by a chronic nonspecific 
dermatitis that does not have diagnostic features of 
MF histologically, yet harbors a dominant T-cell clone. 
This observation has been termed “clonal dermatitis.” 
Molecular studies have demonstrated that both diseases 
can share the same monoclonal population. Thus, clonal 
dermatitis may represent a subgroup of patients who are 
at increased risk of developing clinically overt MF. Future 
studies could help determine their long-term risk of MF. It 
is necessary to closely follow these patients to diagnose 
lymphoma at the earliest possible time and to institute the 
correct treatment (Bottaro et al., 1994).
What does the future hold for this molecular technique? 
This highly sensitive tool enables earlier and more accu-
rate diagnosis of CTCL. With further studies and greater 
understanding of the pathogenesis of cutaneous lympho-
mas, these tools may be used for more precise disease 
staging and the ability to provide better prognostic infor-
mation for patients, thus allowing for more tailored treat-
ment (Wood, 2001; Gellrich et al., 2000).
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